UBS Group’s Roundhill GLP-1 & Weight Loss ETF OZEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$285K Buy
9,145
+3,862
+73% +$131K ﹤0.01% 6429
2025
Q4
$180K Sell
5,283
-9,721
-65% -$303K ﹤0.01% 6634
2025
Q3
$410K Buy
15,004
+9,974
+198% +$257K ﹤0.01% 6235
2025
Q2
$127K Sell
5,030
-783
-13% -$19K ﹤0.01% 7040
2025
Q1
$138K Buy
5,813
+5,762
+11,298% +$142K ﹤0.01% 6802
2024
Q4
$1.24K Sell
51
-314
-86% -$8.45K ﹤0.01% 9283
2024
Q3
$10.1K Buy
+365
New +$10.1K ﹤0.01% 7748

Other funds holding OZEM

UBS Group's OZEM Position: Q1 2026 in Review

UBS Group increased its Roundhill GLP-1 & Weight Loss ETF (OZEM) stake by 73% in Q1 2026, buying an estimated $131K and bringing the position to 9,145 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #6429.

UBS Group first reported a position in OZEM in Q3 2024 and has held it in 7 quarters since. The position peaked at $410K in Q3 2025. 25 funds tracked by Wall St. Rank hold OZEM as of Q1 2026.

  • UBS Group held 9,145 shares of Roundhill GLP-1 & Weight Loss ETF worth $285K as of Q1 2026.
  • UBS Group bought 3,862 Roundhill GLP-1 & Weight Loss ETF shares in Q1 2026, an estimated $131K.
  • Roundhill GLP-1 & Weight Loss ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6429 holding.
  • UBS Group first reported a position in Roundhill GLP-1 & Weight Loss ETF in Q3 2024 and has held it in 7 quarters since.
  • UBS Group's Roundhill GLP-1 & Weight Loss ETF position peaked at $410K in Q3 2025.
  • 25 funds tracked by Wall St. Rank held Roundhill GLP-1 & Weight Loss ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.